Current Report Filing (8-k)
April 04 2014 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 3, 2014
BioTelemetry, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
|
000-55039 |
|
46-2568498 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
1000 Cedar Hollow Road
Malvern, PA |
19355 |
(Address of Principal Executive Offices) |
(Zip Code) |
Registrants telephone number, including area code: (610) 729-7000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On April 3, 2014 BioTelemetry, Inc. (the Company), through its wholly-owned subsidiary CardioNet, LLC (CardioNet), completed its previously announced acquisition of substantially all of the assets of the cardiac event monitoring business of Biomedical Systems Corporation (the Seller) pursuant to the terms and conditions of an Asset Purchase Agreement between CardioNet and the Seller (the Purchase Agreement).
Item 2.01 Completion of an Acquisition or Disposition of Assets
The information set forth in Item 1.01 above is incorporated by reference herein. A copy of the Purchase Agreement was previously filed as an exhibit to the Companys Form 8-K filed on March 20, 2014.
Reference is made to Item 1.01 of the Form 8-K filed on March 20, 2014, which is hereby incorporated by reference herein.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BioTelemetry, Inc. |
|
|
|
|
|
By: |
/s/ Peter Ferola |
|
|
Peter Ferola |
|
|
Senior Vice President and General Counsel |
Date: April 4, 2014 |
|
3
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Aug 2023 to Aug 2024